Today's Health Winners and Losers
Shares of Providence Service (PRSC) rose 6% after the company priced its follow-on stock offering at $32 a share. The company, which provides home- and community-based social services, priced 1.8 million shares, up from its earlier figure of 1.5 million shares. Of the 1.8 million shares, the company offered some 1.73 million, up from the company's earlier projection of 1.43 million.
The remaining shares were sold by stockholders. Providence plans to use the proceeds to pay down debt and for general corporate purposes. Shares were up $1.85 to $34.05.
Given Imaging (GIVN) fell 2% after the company, a maker of diagnostics products for disorders of the gastrointestinal tract, cut its first-quarter sales outlook and warned that earnings would be below expectations. The company estimates sales of about $20.2 million, down from an earlier view of $21 million to $23 million. Analysts polled by Thomson First Call project sales of $22.8 million.
The company also warned that, as a result of the sales shortfall, its earnings would fall short of its previous guidance of 1 cent to 3 cents a share. Analysts project earnings of 2 cents a share. Given Imaging blamed the lower-than-expected sales on a 50% ramp-up in its U.S. sales force and by the accompanying training and adjustments necessary to integrate the increased sales force.For the full year, Given Imaging continues to expect earnings of 35 cents to 45 cents a share and sales of $110 million to $120 million. Analysts project earnings of 34 cents a share on sales of $108.4 million. Shares were down 47 cents to $22.41. Other health care volume movers included Pfizer (PFE), down 44 cents to $24.21; UnitedHealth Group (UNH), down $1.15 to $51.28; Boston Scientific (BSX), down 17 cents to $21.36; Merck (MRK), down 44 cents to $33.98; Johnson & Johnson (JNJ), down 25 cents to $57.46; Novavax (NVAX), down 17 cents to $4.97; Generex Biotechnology (GNBT), down 20 cents to $2.53; Amgen (AMGN), down 68 to $70.06; Bristol-Myers Squibb (BMY), down 25 cents to $24.02; and Schering-Plough (SGP), down 30 cents to $18.40.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV